Translation in the news

Gene editing technology licensed
for human therapeutics

CRISPR-Cas9 gene editing tools developed by Wyss Institute Core Faculty Member George Church and his collaborators have been licensed to Editas Medicine to develop therapies that could work by disrupting or modifying specific genes

Read More

From the Newsroom

  • DNA Nanoswitch Gel

    Revealing the behavior of life's molecules

    DNA nanoswitches, developed by Wyss Associate Faculty member Wesley Wong, are inexpensive new tools to detect and report bio-molecular interactions, reducing experimental costs and opening new doors to drug discovery and disease research Read More

  • E. coli

    Sentencing genetically
    modified organisms
    to life in the lab

    A new study in Nature by Wyss Core Faculty member George Church, Ph.D, shows how a biological "safety lock" can prevent genetically engineered E. coli from escaping into the environment Read More

Media Coverage




  • Diabetes Symposium

    Wyss Annual Diabetes Symposium, Lower Extremity: Innovations and Discovery

    March 27, 2015

    This one-day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.

    Read more Other events


















We've won a Webby Award!

Wyss Institute is a winner of the 2012 Webby Awards in the Science category.